Givat Shaul, Israel

Mark Zamansky

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Zamansky: Innovator in Pharmaceutical Fibrous Structures

Introduction

Mark Zamansky is a notable inventor based in Givat Shaul, Israel. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of fibrous structures that incorporate active pharmaceutical ingredients. His innovative work has the potential to enhance drug delivery systems and improve patient outcomes.

Latest Patents

Mark Zamansky holds a patent for "Finished fibrous structures and methods of their use and preparation." This patent focuses on fibrous structures that are finished with active pharmaceutical ingredients, detailing methods for their manufacture and application. His work in this area represents a significant advancement in the integration of pharmaceuticals with novel materials.

Career Highlights

Zamansky is associated with Clexio Biosciences Ltd., a company dedicated to advancing biopharmaceutical technologies. His role at Clexio has allowed him to explore innovative solutions in drug formulation and delivery. With a patent portfolio that includes 1 patent, he continues to push the boundaries of pharmaceutical research.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Erez Koren and Itzhak Shalev. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biopharmaceuticals.

Conclusion

Mark Zamansky's contributions to the field of pharmaceutical fibrous structures exemplify the impact of innovation in healthcare. His work not only advances scientific knowledge but also holds promise for improving therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…